Roivant Sciences officer proposes $5.15M share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Richard Pulik, an officer of Roivant Sciences Ltd. (ROIV), filed an amended Form 144 notice of a proposed sale of 125,000 common shares, with an approximate sale date of November 10, 2026 and an aggregate market value of $5,150,575.00. Morgan Stanley Smith Barney LLC is named as broker. The shares are listed as acquired on November 10, 2026 through exercise of options under a registered plan, with cash payment. The amendment updates Pulik’s relationship to the issuer as officer.
Key Figures
Key Terms
Form 144 regulatory
Aggregate Market Value financial
Exercise of Options Under a Registered Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.